Evolution of Drug-Eluting Stents: A Biomedical Engineering Breakthrough in Cardiovascular Intervention

Authors

  • Kaustubh Nilesh Mahajan kaustubh.mahajan04@gmail.com

DOI:

https://doi.org/10.36676/urr.v12.i3.1561

Keywords:

Drug-Eluting Stents, Cardiovascular Intervention

Abstract

When compared to bare-metal stents, drug-eluting stents (DES) dramatically lower restenosis rates, revolutionizing interventional cardiology. With an emphasis on stent design, medication selection, and polymer coatings, this paper examines the developments in DES technology. The creation of biodegradable polymers, the optimization of medication release kinetics, and the switch from first- to second- and third-generation stents are some of the major trends identified by a systematic review of research published between 2010 and 2023. Even with these developments, problems like biocompatibility and late stent thrombosis still exist. This study emphasizes the necessity for novel materials and customized strategies to further improve the effectiveness and safety of DES.

References

Downloads

Published

2025-07-02
CITATION
DOI: 10.36676/urr.v12.i3.1561
Published: 2025-07-02

How to Cite

Kaustubh Nilesh Mahajan. (2025). Evolution of Drug-Eluting Stents: A Biomedical Engineering Breakthrough in Cardiovascular Intervention. Universal Research Reports, 12(3), 1–9. https://doi.org/10.36676/urr.v12.i3.1561

Issue

Section

Original Research Article